To compare three first grade medicines for molluscum contagiosum from boerickes clinical repertory

A Prospective Comparative Clinical Study Of First Grade Homoeopathic Medicine From Boerickes Clinical Repertory In The Management Of Molluscum Contagiosum In Paediatric Population - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/09/095037

Enrollment

Registered

2025-09-18

Start date

Unknown

Completion date

Unknown

Last updated

2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B081- Molluscum contagiosum

Interventions

Intervention1: Bromium Silicea Calcarea arsenicosa: Selected medicine potency as per susceptibility 2 globules thrice a day for 3 months Control Intervention1: Bromium Silicea Calcarea arsenicosa: Sel

Eligibility

Inclusion criteria

Inclusion criteria: Patient in paediatric age group Patient giving voluntary consent and assent for study Cases of Molluscum Contagiosum Pre diagnosed cases of Molluscum

Exclusion criteria

Exclusion criteria: Cases refuse to give consent and assent for study Cases with less than 6 follow ups or 3 months of treatment Cases with advanced systemic disorders

Design outcomes

Primary

Measure	Time frame
Safe resolution of lesions Strengthened immune reponse with less recurrenceTimepoint: Assessed in 4 weeks 8 weeks 12 weeks	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactShivangi Jain

Dr. Madan Pratap Khunteta Homoeopathic Medical College Hospital and Research Centre Jaipur

angel.jain240@gmail.com9509227987

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026